Universal Technical Institute Stock Price and Value Analysis

Universal Technical Institute (NYSE:UTI) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

  • Ticker: UTI (NYSE)
  • Current price: $17.17
  • Sector: Unknown
  • Industry: Unknown

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Universal Technical Institute to reach your target.

Target type

UTI Free Cash Flow Trend

Free Cash Flow trendline for UTI
Free Cash Flow trendline for Universal Technical Institute
CSV

Based on historical returns, we believe that Universal Technical Institute can grow its free cash at a rate of about 3%. That's positive!

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This stock looks overpriced.
  • This company is making money at a modest rate.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the UTI Numbers

UTI Price
(Universal Technical Institute stock price per share)
$17.17
[?] UTI Fair Price
(based on intrinsic value)
$5.96
[?] UTI Safety Price (based on a variable margin of safety) $3.87
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 5% lower than other Unknown stocks
[?] PE Ratio versus Industry 1% lower than other Unknown stocks
[?] Cash Yield 0.00%
[?] Free Cash Flow Jitter 195%

Insider Activity Summary

In the six months to 2026-11-21, 1 insider bought in 4 trades, about $295 thousand, and 4 insiders sold in 5 trades, about $128 million.

The six months before that had 6 buys and 9 sales.

Net open-market activity was sales of about $128 million.

Recent Insider Activity

Open-market buys and sells reported by Universal Technical Institute's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.

Date Insider Type Shares Price
2026-08-27 DEVINCENZI ROBERT THOMAS Buy 1,000 $21.80
2026-08-25 DEVINCENZI ROBERT THOMAS Buy 1,000 $21.77
2026-08-12 DEVINCENZI ROBERT THOMAS Buy 1,000 $25.95
2026-08-10 DEVINCENZI ROBERT THOMAS Buy 8,000 $28.21
2026-06-29 Grant Jerome Alan (Chief Executive Officer) Sell 48,961 $41.63
2026-06-29 Grant Jerome Alan (Chief Executive Officer) Sell 45,539 $41.15
2026-06-22 Prehn Kevin (Concorde Division President) Sell 4,545 $40.00
2026-06-08 Coliseum Capital Management, LLC Sell 3,000,000 $41.40
2026-06-05 Kline Christine (Senior Vice President and CAO) Sell 3,500 $44.42
2026-05-11 SRERE LINDA J Sell 15,000 $36.59

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 7,693,508 shares shorted. With 53,804,724 shares available for purchase and an average trading volume over the past 10 trading days of 1,561,440, it would take at least 4.9 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2009 1261654 20.9
2010 1261654 34.6
2011 1261654 26.5
2012 1261654 -7.6
2013 1261654 3.6
2014 1261654 7.3
2015 1261654 -9.9
2016 1261654 -6.5
2017 1261654 -12.1
2018 1261654 -28.8
2019 1261654 7.4
2020 1261654 0.6
2021 1261654 34
2022 1261654 10.6
2023 1261654 6.5
2024 1261654 39.7
2025 1261654 44.6

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 12 fiscal years from 2009 to 2025 with positive net income, operating cash flow totaled $592 million against net income of $248 million, or 2.39 times. Net income was negative in 5 of the 17 years, and those years are left out of the ratio.

In 2025, operating cash flow was 1.54 times net income, compared with 2.60 times for the earliest three years (2009 to 2011).

In 2025, capital expenditures were $42 million, 43.1% of operating cash flow of $97.3 million, which leaves an estimated $55.4 million after capex. Across the 16 years with reported capex, it averaged 71.6% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Cash conversion in 2025 was 1.54, at least 0.25 under the 2.60 earliest three-year ratio. Gaps like this come from non-cash gains or from cash tied up in receivables, inventory or other working capital.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2009 11.7 49.5 28.5 4.22
2010 28.6 67.5 37.2 2.36
2011 26.9 58.1 29.1 2.16
2012 9.1 18.9 11.3 2.08
2013 3.9 26.7 9.4 6.85
2014 2 27.1 12 13.28
2015 -9.1 8.2 29 n/a
2016 -47.7 7.4 7.5 n/a
2017 -8.1 1.1 8.2 n/a
2018 -32.7 -13.4 20.6 n/a
2019 -7.9 21.7 6.5 n/a
2020 8 11 9.3 1.38
2021 14.6 55.2 61.3 3.78
2022 25.8 46 79.5 1.78
2023 12.3 49.1 56.7 3.99
2024 42 85.9 24.3 2.05
2025 63 97.3 42 1.54

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 8 fiscal years from 2009 to 2024 with dividend or share repurchase facts, estimated free cash flow totaled $82.1 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 6 of those years with dividend payment facts, dividends paid totaled $72.2 million, 336.1% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 0 of those 6 years.

In 4 of the 8 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $35.4 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2024, cash spent repurchasing shares was $11.6 million, 29.3% of estimated free cash flow of $39.7 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2009 20.9 n/a 16.9 16.9 80.9%
2010 34.6 36.3 n/a 36.3 104.9%
2012 -7.6 7.4 1.8 9.3 n/a
2013 3.6 9.8 5.4 15.2 420.5%
2014 7.3 9.9 1.4 11.3 155.8%
2015 -9.9 7.3 6.6 13.9 n/a
2016 -6.5 1.5 n/a 1.5 n/a
2024 39.7 n/a 11.6 11.6 29.3%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $367 million in 2009 and $836 million in 2025, a compound annual growth rate of 5.3% over 16 years.

Revenue rose 14.0% from 2024 to 2025.

Our estimated free cash flow was $44.6 million in 2025, 5.3% of revenue. In 2009 the estimated margin was 5.7%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2009 367 20.9 5.7%
2010 436 34.6 7.9%
2011 452 26.5 5.9%
2012 414 -7.6 -1.8%
2013 380 3.6 1.0%
2014 378 7.3 1.9%
2015 363 -9.9 -2.7%
2016 347 -6.5 -1.9%
2017 324 -12.1 -3.7%
2018 317 -28.8 -9.1%
2019 332 7.4 2.2%
2020 301 0.6 0.2%
2021 335 34 10.2%
2022 419 10.6 2.5%
2023 607 6.5 1.1%
2024 733 39.7 5.4%
2025 836 44.6 5.3%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $127 million against total liabilities of $498 million, or 25.6% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 60.3% of total assets in 2025, compared with 55.4% in 2010, an increase of 4.9 percentage points.

Stockholders equity was $328 million in 2025, compared with $108 million in 2010, a rise of 203.7%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 9.5% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2010 243 44.6 134 108
2011 266 52.2 124 142
2012 269 44.6 122 146
2013 280 34.6 141 139
2014 288 39 155 133
2015 274 29.4 161 113
2016 297 119 161 137
2017 274 50.1 148 126
2018 282 58.1 156 127
2019 271 65.4 156 114
2020 442 76.8 265 177
2021 513 134 324 189
2022 553 66.5 338 215
2023 741 152 515 226
2024 745 162 484 260
2025 826 127 498 328

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $17.17, the price is above what our model can produce for average free cash flow growth between -30 and 60 percent a year, so no implied growth rate is shown. Our model assumes 2.8 percent a year for this stock. This is not a forecast of growth or a price target.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $0 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $13.74 above range
Current price $17.17 above range
20 percent above the current price $20.60 above range
Our model (stored fair price) $5.96 2.8%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

Universal Technical Institute reported positive free cash flow in 12 of the 17 fiscal years we have from its current SEC filer.

Average free cash flow over the last three years of data was $30.3 million, and across the first three years it was $27.3 million; over the period it rose.

Year-to-year variability in free cash flow is volatile, measured at 195%.

At $17.17, the price is above our fair value estimate of $5.96 for Universal Technical Institute.

We do not have a dividend yield for Universal Technical Institute.

Our value investing guide explains how to test these numbers against the filings themselves.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1261654.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow was negative in 5 of the 17 years we have.
  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: UTI annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in UTI

Does Universal Technical Institute have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: UTI

This example shows how we apply the Trendshare checklist to UTI: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 17.17
    • Market cap: $946M
    • EPS: 0.61
  2. Step 2 — Valuation checks

    • P/E: 28.148
    • FCF yield: 0.0%
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.